Phenotypic, genotypic, and metabolic resistance mechanisms of ESKAPE bacteria to chemical disinfectants: a systematic review and meta-analysis
Authors:
- 14 September 2023
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 21 (10) , 1097-1123
Abstract
The presence of resistant ESKAPE pathogens to antimicrobials including chemical disinfectants (ChDs) is a serious threat to public health worldwide. In the present study, we systematically reviewed published reports on mechanisms beyond ChD resistance of ESKAPE bacteria. Several databases without date limitations were searched. Studies focused on the ChD resistance/tolerance mechanisms of ESKAPE bacteria were included. Meta-analysis was done to assess the frequency of tolerance and genes in ESKAPE clinical isolates. By screening of initial 6733 records, finally, 41 studies were included. The overall tolerance to at least one ChD was 48.6%. Pseudomonas aeruginosa and Acinetobacter baumannii were highly ChD-resistant. In several studies, phenotypic changes including changes in general morphology, pump function, cell surface, and membrane, as well as metabolic changes were observed after ChD addition. The resistance gene frequency was 70.2% for norfloxacin efflux pump genes, 40.6% for qac major facilitator superfamily genes, and 22.2% for qac small multidrug resistance genes. We systematically reviewed the effect of various mechanisms in the resistance process of ESKAPE bacteria to ChDs. However, except for the impact of genes, the numbers of studies investigating other mechanisms were very limited, demanding carrying out more studies in this field.Keywords
Funding Information
- Kermanshah University of Medical Sciences
This publication has 75 references indexed in Scilit:
- Reduced susceptibility to chlorhexidine among extremely-drug-resistant strains of Klebsiella pneumoniaeJournal of Hospital Infection, 2012
- Molecular and functional characterization of a novel efflux pump, AmvA, mediating antimicrobial and disinfectant resistance in Acinetobacter baumanniiJournal of Antimicrobial Chemotherapy, 2010
- Triclosan Resistance of Pseudomonas aeruginosa PAO1 Is Due to FabV, a Triclosan-Resistant Enoyl-Acyl Carrier Protein ReductaseAntimicrobial Agents and Chemotherapy, 2010
- Efflux-Mediated Drug Resistance in BacteriaDrugs, 2009
- Triclosan resistance in clinical isolates of Acinetobacter baumanniiJournal of Medical Microbiology, 2009
- MexCD-OprJ Multidrug Efflux System of Pseudomonas aeruginosa : Involvement in Chlorhexidine Resistance and Induction by Membrane-Damaging Agents Dependent upon the AlgU Stress Response Sigma FactorAntimicrobial Agents and Chemotherapy, 2008
- Multidrug efflux pump overexpression in Staphylococcus aureus after single and multiple in vitro exposures to biocides and dyesMicrobiology, 2008
- Efflux-Related Resistance to Norfloxacin, Dyes, and Biocides in Bloodstream Isolates ofStaphylococcus aureusAntimicrobial Agents and Chemotherapy, 2007
- Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in BacteriaClinical Microbiology Reviews, 2006
- Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilutionClinical Microbiology and Infection, 2003